An Open-Label, Randomized, Phase IIIB Trial Evaluating the Efficacy and Safety of Standard of Care +/- Continuous Bevacizumab Treatment beyond Progression of Disease (PD) in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  • Jones, Dennie (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date3/3/129/30/14